Microepidemics in the Carriage of Streptococcus Pneumoniae - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Microepidemics in the Carriage of Streptococcus Pneumoniae

Description:

Streptococcus pneumoniae (Pnc) is a bacterial pathogen that ... Ts- (sojourn) 0.22. 0.58. 0.33. Ps (prop DCC) 0.01. 0.12. 0.03. Ps (prop ind) 19F. 9V. 18C ... – PowerPoint PPT presentation

Number of Views:90
Avg rating:3.0/5.0
Slides: 24
Provided by: nbbc07
Category:

less

Transcript and Presenter's Notes

Title: Microepidemics in the Carriage of Streptococcus Pneumoniae


1
Micro-epidemics in the Carriage of Streptococcus
Pneumoniae
  • Fabian Hoti, Kari Auranen

2
Outline
  • Introduction
  • Pneumococcus
  • Vaccination
  • The Pneumocarr project
  • Modelling transition dynamics
  • The PNCeuro data
  • Micro-epidemics
  • Characterizing quantities
  • Preliminary Results

3
Introduction
  • Streptococcus pneumoniae (Pnc) is a bacterial
    pathogen that accounts for over one million
    annual deaths in children
  • Pneumococcal diseases include meningitis,
    pneumonia, and otitis media.
  • Pneumococcus is part of the natural flora in
    human nasopharynx
  • Pneumococcus has 90 different serotypes capsules
    that the human immune system may react to

4
Introduction vaccination
  • A conjugate vaccine providing partial protection
    against 7 serotypes has been licensed
  • Introduction of the conjugate vaccine in US
    revealed a strong herd immunity effect as well as
    evidence on serotype replacement
  • Herd immunity reduction in exposure due to less
    potential spreading routes
  • Serotype replacement removed serotypes are
    replaced by others

5
The Pneumocarr project
  • A five year project founded by the Grand
    Challenges in Global Health Initiative
  • The main goal of the project is to establish
    colonization as a measure of the effectiveness of
    vaccination.
  • Reduction in carriage ? reduction in disease
  • Serotype specific serological correlates of
    protection (antibodies)
  • Carriage is very common ? less study individuals
    needed? reduced cost

6
Modeling goals
  • To understand the transition dynamics of
    serotype carriage (acquisition/clearance)
  • To understand the role of between serotype
    competition (replacement)
  • To understand the micro-epidemic nature of the
    carriage episodes (this talk)

7
Cross-sectional swab data
  • Problems
  • Acquisition and clearance times unknown
  • All short carriage episodes are not detected

8
Cross-sectional swab data
  • Possible solution
  • Characterize episodes by acquisition and
    clearance rates
  • Model acquisition and clearance rates by
    parameterized models
  • Continuous time approach (Auranen, 2000
    Cauchemez, 2006)
  • Carriage episodes are handled by latent processes
    (Bayesian data-augmentation)
  • A Markov chain Monte Carlo algorithm is used to
    sample over possible carriage episodes and
    produce estimates of the model parameters

9
Transition intensities
  • Individual based transition rates (age, exposure)
  • Carriage of one serotype reduces/increases the
    colonization rates of other serotypes

Serotype 1
Competition parameter
Non-carrier
Serotype 2
10
PNCeuro data
  • a KTL data set
  • 3 day care centres in Tampere, Finland
  • Index children family members employees
  • 10 monthly nasopharyngeal swabs

11
Composition of Cohort
12
Distribution of Family Compositions
13
Number of swabs in DCCs
14
Micro-epidemic behavior
  • The dominant types 9V,19F, and18C were detected
    in one dcc only
  • 18C and 9V are rare types
  • 23F was not detected at all (usually one of the
    most prevalent)

15
Micro-epidemics in DCCs
  • Serotype specific quantities describing the
    micro-epidemics
  • The stationary prevalence of individual carriers
    (ps)
  • The mean waiting time until next micro-epidemic
    (Ts-)
  • The stationary prevalence of DCCs carrying (Ps)
  • The mean duration of a micro-epidemic (Ts)
  • The mean size of a micro-epidemic (ms)
  • The rate a typical carrier of serotypes s makes
    infectious contacts to the community (?s)
  • The average number of infectious contacts
    emanated from a single outbreak (As)

16
Micro-epidemics
  • The mean waiting time until next micro-epidemic
    (Ts-)

Proportion of carriers of other serotypes
Proportion of non carriers
17
Micro-epidemics in DCCs
  • The mean duration of a micro-epidemic (Ts)

18
Micro-epidemics in DCCs
  • The rate a typical carrier of serotype s makes
    infectious contacts to the community (?s)
  • We assume the population consists of n DCCs sized
    N only
  • Thus the total force of infection generated by
    the DCCs must equal the total acquisition
    pressure on the DCCs

19
Micro-epidemics in DCCs
  • The average number of infectious contacts
    emanated from a single outbreak (As)

Average duration
Average number of carriers in a micro-epidemic
20
Micro-epidemics in DCCs
21
  • Thanks !!
  • www.pneumocarr.org

22
Structured Population (3)
  • The acquisition rate of serotype s for individual
    i at time t can be modeled as

Community
Within day care centre
Within family
23
Structured Population (4)
  • To consider age-specific susceptibility and
    infectiousness, age-specific parameters can be
    introduced
  • For an individual in age group b the
    acquisition rate of serotype s from the mixing
    group family is

Number of family members in age group a at time t
Number of age groups
Write a Comment
User Comments (0)
About PowerShow.com